focus -WSS

focus

author：focus 2025-09-28 02:31:54 - browse：32

Doctor sitting at a crowded desk. -- first opinion coverage from STAT — Adobe

SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

“It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Medicare Advantage isn’t working — for anyone

hotspot

WSS

Surprise medical billing ban raises prices elsewhere

Redefining sustainability for the pharmaceutical industry

5 ways to address the shortage of health care workers

In 'major milestone,' FDA approves first cell therapy for solid tumors

Obamacare plans could cover weight loss drugs

Medicare Advantage enrollment hits roughly 33.4 million

leisure time

focus

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Ukraine seeks to reclaim its role as a hub for clinical trials

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Cancer drug shortages should be causing more outrage

CDC advisory group OKs chikungunya vaccine

Guidelines to prevent youth baseball injuries need more muscle

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

In 'major milestone,' FDA approves first cell therapy for solid tumors

leisure time

Weight loss drugs aren’t covered by Obamacare. That may change

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

In 'major milestone,' FDA approves first cell therapy for solid tumors

FDA warns medical device makers about rise in fabricated data

Medicare isn't yet testing food as medicine

hotspot

hotspot

explore

entertainment